Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
33 hedge funds and large institutions have $8.32M invested in Biocept, Inc. in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.
250% more call options, than puts
Call options by funds: $616K | Put options by funds: $176K
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
27% more funds holding
Funds holding: 26 → 33 (+7)
2% more capital invested
Capital invested by funds: $8.12M → $8.32M (+$198K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$667K |
| 2 |
JP Morgan Chase
New York
|
+$262K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$239K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$197K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$831K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$371K |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
-$336K |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$89.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$50K |
BIOC Hedge Fund Activity: Q4 2021 in Review
33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2021, worth a combined $8.32M — up 2.4% from $8.12M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BIOC positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Ameriprise, adding an estimated $667K. The largest seller was Bank of Montreal, exiting entirely with an estimated $831K sold.
- 33 institutional investors held Biocept, Inc. (BIOC) as of Q4 2021, up from 26 in Q3 2021.
- Funds reported $8.32M of Biocept, Inc. stock for Q4 2021, up 2.4% quarter-over-quarter.
- 12 funds opened new Biocept, Inc. positions in Q4 2021 and 5 closed out, a net change of +7 holders.
- The largest Biocept, Inc. buyer in Q4 2021 was Ameriprise, an estimated $667K added.
- The largest Biocept, Inc. seller in Q4 2021 was Bank of Montreal, an estimated $831K sold.
Based on aggregated 13F filings for Q4 2021.